Thus, novel agents that activate Bax/Bak-independent programmed cell death mechanisms (i.e., ferroptosis, mitoptosis, pyroptosis, etc.)are gaining increasing interest as alternative cancer treatments (65). The gene discussed is BAX; the disease is cancer.